Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An adenocarcinoma that arises from the vulva. Representative examples include Bartholin gland adenocarcinoma, eccrine adenocarcinoma, apocrine adenocarcinoma, and sebaceous carcinoma.
Biomarker and diagnostic research for vulvar adenocarcinoma has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and biologic therapy. Pipeline includes 1 PHASE2, 1 PHASE1. Research is primarily industry-sponsored.
69 publications have been identified in PubMed for vulvar adenocarcinoma. Research spans Case Report / Case Series (61%), Review / Meta-Analysis (16%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 42 | 61% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 11 | 16% |
Laboratory research | 7 | 10% |
Disease patterns and progression | 5 | 7% |
Testing and diagnosis research | 2 | 3% |
Clinical study results | 2 | 3% |
Nobile I (2026). [PMID: 41641105](https://pubmed.ncbi.nlm.nih.gov/41641105/). *Frontiers in oncology*. [Review / Meta-Analysis]
Yoakam M (2026). [PMID: 41994808](https://pubmed.ncbi.nlm.nih.gov/41994808/). *Cureus*. [Case Report / Case Series]
Heller A (2026). [PMID: 40960653](https://pubmed.ncbi.nlm.nih.gov/40960653/). *International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists*. [Diagnostic / Biomarker]
Bahsas Zaky O (2026). [PMID: 29630276](https://pubmed.ncbi.nlm.nih.gov/29630276/). *Unknown Journal*. [Review / Meta-Analysis]
Consing Gangelhoff M (2026). [PMID: 40372962](https://pubmed.ncbi.nlm.nih.gov/40372962/). *International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists*. [Case Report / Case Series]
Chang L (2026). [PMID: 42133445](https://pubmed.ncbi.nlm.nih.gov/42133445/). *Cancer Control*. [Epidemiology / Natural History]
Ahn J (2026). [PMID: 41648269](https://pubmed.ncbi.nlm.nih.gov/41648269/). *bioRxiv : the preprint server for biology*. [Basic Science / Preclinical]
Yagi A (2026). [PMID: 42120649](https://pubmed.ncbi.nlm.nih.gov/42120649/). *Sci Rep*. [Epidemiology / Natural History]
Aung TH (2026). [PMID: 41251094](https://pubmed.ncbi.nlm.nih.gov/41251094/). *Diagnostic cytopathology*. [Case Report / Case Series]
Nakra G (2026). [PMID: 41944460](https://pubmed.ncbi.nlm.nih.gov/41944460/). *Int J Surg Pathol*. [Case Report / Case Series]